News

Inside Isomorphic Labs, the secretive AI life sciences startup spun off from Google DeepMind
Isomorphic Labs is the secretive AI life sciences startup spun out of Google DeepMind with the goal of solving all disease ...
DeepMind AI staff reportedly tied to Google with "aggressive" noncompete clause — Preventing them from joining rivals like Microsoft but offering year-long PTO
Google DeepMind leverages noncompete agreements to prevent its AI staff from defecting to rival AI firms for up to a year.
GEN - Genetic Engineering and Biotechnology News9d
DeepMind Spinout Isomorphic Labs Raises $600M Toward AI Drug Design
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
The Next Web7dOpinion
DeepMind’s new research restrictions threaten AI innovation, warns Iris.ai CEO
Google DeepMind has reportedly restricted on sharing research will stifle AI innovation, warns the CEO of Iris.ai, one of ...
Google DeepMind has a weapon in the AI talent wars: aggressive noncompete rules
Some Google DeepMind staff are subject to noncompete agreements that stop them working for a rival for up to a year.
Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Microsoft’s AI division wants to create ‘a true personal’ companion
The race to build the best AI personal assistant that sticks with consumers is a competitive one, and Microsoft is diving in.
eWeek7d
‘Solving All Disease’ Using AI is the Mission of Alphabet’s Isomorphic Labs – Its $600M in Funding Will Help
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Google DeepMind outlines safety framework for future AGI development
Though the paper does discuss AGI through what Google DeepMind is doing, it notes that no single organization should tackle ...
Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 ...